Studies on the initiation and regression of atherosclerosis
Studies on the initiation and regression of atherosclerosis
批准号:
05044163
负责人:
KITA Toru
金额:
$6.4万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994
中文摘要
采用一种新的内源性高胆固醇血症动物模型--Watanabe遗传性高脂血症兔,观察了动脉粥样硬化病变分别用抗VCAM-1抗体、巨噬细胞抗体和T淋巴细胞抗体覆盖血管内皮细胞前后血管内皮细胞、巨噬细胞和T淋巴细胞的顺序性表达。由于我们的实验目的是连续分析WHHL-兔动脉壁上发生了什么,所以我们选择了检测VCAM-1、巨噬细胞和T淋巴细胞表达和存在的地方,即肋间动脉第一支的开口。1月龄WHHL兔肋间动脉开口处可见VCAM-1分子表达,2月龄时VCAM-1分子覆盖于管壁周围。此外,此时单核细胞开始在动脉壁内积聚,称为内膜军团。三到四周后的…在同一内膜间隙内可见更多的T淋巴细胞。1987年,我们报道了抗氧化剂普罗布考抑制WHHL兔动脉粥样硬化军团的进展。1991年,我们报道普罗布考治疗组动脉粥样硬化斑块中巨噬细胞来源的泡沫细胞比未治疗组少。为了解释这些现象,我们正在考虑普罗布考以某种方式抑制血管内皮细胞VCAM-1表达的可能性,目前这种可能性正在研究中。此外,我们还在体外研究了WHHL兔血管内皮细胞表面VCAM-1的诱导机制以及另一种单核细胞黏附分子ICAM-1。溶血磷脂酰胆碱(Lyso-PC)是动脉粥样硬化病变中产生的一种血管内皮细胞黏附分子-1和细胞间黏附分子-1的表达上调因子。在ICAM-1中,这种分子的诱导不依赖于PMA可调节的PKC的激活,而被细胞内循环AMP水平的升高所抑制。因此,我们与Chait博士和Gimbrone博士合作,重点研究了Lyso-PC对ICAM-1和VCAM-1表达的信号转导系统。较少
英文摘要
Using a new animal model for endogenous hypercholesterolemia, named Watanabe-heritable-hyperlipidemic rabbit, which has a severe fulminant atherosclerosis, we have investigated the sequential expression of monocyteadhesion molecule (VCAM-1), macrophages and T lymphocytes in and on the endothelial monolinear before and after the atherosclerotic lesions covered the space by anti-VCAM-1, macrophage and T lymphocyte antibody respectively. Because our experimental purpose is sequential analysis what is going on the arterial wall in WHHL-rabbit, we chose the place where we examined the expression and existence VCAM-1, macrophage and T lymphocyte, that is the orifice of first branch of intercostal artery. At one month of age WHHL-rabbit, expression of VCAM-1 molecules is observed at the orifice of intercostal artery and covered around the wall at 2 month of age. In addition, at that time, monocytes started to accumulate in the arterial wall, named intimal legion. Three to four weeks later of … More this phenomenon T lymphocytes are observed in the same intimal space. In 1987, we reported that antioxidant, probucol, suppressed the progression of atherosclerotic legions in WHHL-rabbit. In 1991, we reported that in the atherosclerotic legions in probucol treated group there were few macrophage derived foam cells than untreated group. to explain these phenomenon we are thinking the possibility which probucol somehow inhibits the expression of VCAM-1 expression in the endothelial cells and this possibility is now under examined. The mechanism why VCAM-1 is induced on the endothelial cell in WHHL rabbit is under investigated in vitro and ICAM-1, another monocyte adhesion molecule, is also examined. Lysophosphatidylcholine (Lyso-PC) which generated in atherosclerotic lesions, has been shown to differentially up regulate VCAM-1 and ICAM-1 expression in various cultured endothelial cells. In case of ICAM-1, induction of this molecules is independent of PMA-regulatable PKC activation but suppressed by increased level of intracellular cyclic AMP.Therefore we focus and put forward on the signal transduction system of Lyso-PC on the expression of ICAM-1 and VCAM-1 collaboration with both Drs. Chait and Gimbrone. Less
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Makoto Tanaka,et al.: "Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes." J.Biol.Cehm.268. 907-911 (1993)
Makoto Tanaka 等人:“根据兔肝细胞内胆固醇酯含量的变化调节载脂蛋白 B 的产生和分泌。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Noriaki Kume,et al.: "Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells." J.Clin.Invest.93. 907-911 (1993)
Noriaki Kume 等人:“溶血磷脂酰胆碱在培养的人内皮细胞中转录诱导生长因子基因表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yasuhiro Hakamata,et al.: "Involvement of the brain type of ryanodine receptor in T-cell proliferation." FEBS Lett. 352. 206-210 (1994)
Yasuhiro Hakamata 等人:“脑型兰尼碱受体参与 T 细胞增殖。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Makoto Tanaka,et al.: "Regulation of apolipoprotein B secretion in hepatocytes from Watanabe heritable hyperlipidemic rabbit,an animal model of familial hypercholesterolemia." Atherosclerosis. in press.
Makoto Tanaka 等人:“渡边遗传性高脂血症兔(一种家族性高胆固醇血症动物模型)肝细胞中载脂蛋白 B 分泌的调节”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Makoto Tanaka, et al.: "Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes." J.Biol.Chem.268. 12713-12718 (1993)
Makoto Tanaka 等人:“根据兔肝细胞内胆固醇酯含量的变化调节载脂蛋白 B 的产生和分泌。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 9 条
Molecular mechanism of the process from atherosclerotic lesion formation to plaque rupture
-
批准号:16209031
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$32.28万
-
财政年份:2004
-
负责人:KITA Toru
-
依托单位:
Cell biological study for atherosclerosis
-
批准号:11694266
-
项目类别:Grant-in-Aid for Scientific Research (A).
-
资助金额:$4.99万
-
财政年份:1999
-
负责人:KITA Toru
-
依托单位:
Molecular mechanism of activation of endothelial cells involved in early stage of atherosclerosis formation.
-
批准号:11307018
-
项目类别:Grant-in-Aid for Scientific Research (A).
-
资助金额:$23.55万
-
财政年份:1999
-
负责人:KITA Toru
-
依托单位:
Molecular Mechanism of Atherosclerosis
-
批准号:09281103
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas (A)
-
资助金额:$128.06万
-
财政年份:1997
-
负责人:KITA Toru
-
依托单位:
動脈硬化の分子機構
-
批准号:09281104
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas (A)
-
资助金额:$165.89万
-
财政年份:1997
-
负责人:KITA Toru
-
依托单位:
Molecular mechanism on the progression of atherosclerosis.
-
批准号:07044255
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$5.63万
-
财政年份:1995
-
负责人:KITA Toru
-
依托单位:
Development of new drug for intractable hyperlipidemia and its clinical application
-
批准号:07557073
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$9.6万
-
财政年份:1995
-
负责人:KITA Toru
-
依托单位:
Gene engineering, cell biological aproaches to the mechanisms for early stage of atherosclerosis
-
批准号:05404039
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$21.25万
-
财政年份:1993
-
负责人:KITA Toru
-
依托单位:
Development and clinical application of novel anti-atherogenic drug.
-
批准号:05557052
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$10.88万
-
财政年份:1993
-
负责人:KITA Toru
-
依托单位:
Establishment of a new antiatherosclerotic drug and its screening methods using an animal model.
-
批准号:03557116
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$10.62万
-
财政年份:1991
-
负责人:KITA Toru
-
依托单位:
Cell and molecular biological approaches to atherosclerosis in an animal model for familial hypercholesterolemia.
-
批准号:03404066
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$17.92万
-
财政年份:1991
-
负责人:KITA Toru
-
依托单位:
Studies on the initiation of atherosclerosis
-
批准号:02044081
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$13.95万
-
财政年份:1990
-
负责人:KITA Toru
-
依托单位:
Study for the pathogenesis of atherosclerosis.
-
批准号:01304063
-
项目类别:Grant-in-Aid for Co-operative Research (A)
-
资助金额:$7.36万
-
财政年份:1989
-
负责人:KITA Toru
-
依托单位:
Study for the mechanism of LDL modification search for its inhibitor.
-
批准号:63870014
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$6.78万
-
财政年份:1988
-
负责人:KITA Toru
-
依托单位:
Study for the initial events of atherosclerosis in WHHL-rabbit and its prevention.
-
批准号:63480270
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.84万
-
财政年份:1988
-
负责人:KITA Toru
-
依托单位:
Study for the initial event of athcrosclerosis.
-
批准号:61480250
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.2万
-
财政年份:1986
-
负责人:KITA Toru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
VCAM-1/β2-MG协同介导新生儿肠道病毒颅内感染机制与靶向干预研究
-
批准号:2026JJ82539
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李军帅
-
依托单位:
钙调蛋白激酶PNCK磷酸化p38/MAPK通路调控黏附因子VCAM-1表达诱导肿瘤-血管定植促进肝癌播散的机制研究
-
批准号:QN25H160126
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:冯龙海
-
依托单位:
基于多组学技术探究β羟基丁酸通过NF-κB/VCAM-1/Rac1信号通路调控星形胶质细胞的增生、趋化与激活而影响脓毒症相关性脑病的机制
-
批准号:2024Y9374
-
项目类别:省市级项目
-
资助金额:45.0万元
-
批准年份:2024
-
负责人:梁进伟
-
依托单位:
VCAM-1通过激活巨噬细胞参与衰老相关心房重构及其机制研究
-
批准号:82370332
-
项目类别:面上项目
-
资助金额:47万元
-
批准年份:2023
-
负责人:刘彤
-
依托单位:
高醛条件下IRF-1诱导VCAM-1 生成调控血管钙化的机制研究
-
批准号:2022JJ30799
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:崔蓉蓉
-
依托单位:
基于铁死亡探讨VCAM-1阳性间充质干细胞外泌体修复老年糖尿病心肌损伤的作用与机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:魏艺萌
-
依托单位:
高效抑制VCAM-1的仿生杂合NO前药自组装纳米粒用于乳腺癌及肺转移的治疗研究
-
批准号:82104100
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:顾国龙
-
依托单位:
E2F2转录调控VCAM-1诱导多发性骨髓瘤耐药的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:郑永江
-
依托单位:
靶向VCAM-1的嵌合抗原受体调节性T细胞免疫疗法治疗腹主动脉瘤的实验研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:张健
-
依托单位:
MicroRNA-122调控VCAM-1/NOS2发挥脑保护作用的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:吕波
-
依托单位: